KRYS Stock Price
Krystal Biotech, Inc.
KRYS stock price is $325.42 (+1.61% on the day), giving Krystal Biotech, Inc. a market cap of $9.48B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
KRYS Stock Overview
- Price
- $325.42
- Previous close
- $320.25
- Open
- $321.80
- Market cap
- $9.48B
- P/E ratio
- 46.3
- 52-week range
- $183.03 - $382.54
- 1-year price target
- $392.10
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NGS
- MarketXLS Rank
- 48
About Krystal Biotech, Inc.
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KRYS | $325.42 | +1.6% | 195.44K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |